Next report date
Report period
Q4 2023
EPS estimate
0.15CNY
Revenue estimate
—
1.64CNY
2.01 BCNY
6.97 BCNY
340.83 M
About PORTON PHARMA SOLU
Sector
CEO
Nian Feng Ju
Headquarters
Chongqing
Website
Employees (FY)
5.33 K
Founded
2005
ISIN
CNE100001S57
FIGI
BBG002Z7JSJ9
Porton Pharma Solutions Ltd. engages in the research, development and manufacture of pharmaceutical products and active pharmaceutical ingredients. It offers anti-viral, anti-diabetic, anti-hypertensive, anti-cancer, analgesic, hypolipidemic, and antibacterial drug treatment. The company was founded on July 7, 2005 and is headquartered in Chongqing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 300363 is 16.98 CNY — it has increased by 2.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange PORTON PHARMA SOLU stocks are traded under the ticker 300363.
PORTON PHARMA SOLU is going to release the next earnings report on Apr 27, 2024. Keep track of upcoming events with our Earnings Calendar.
300363 stock is 3.59% volatile and has beta coefficient of 1.94. Check out the list of the most volatile stocks — is PORTON PHARMA SOLU there?
300363 earnings for the last quarter are 0.19 CNY per share, whereas the estimation was 0.50 CNY resulting in a −62.00% surprise. The estimated earnings for the next quarter are 0.46 CNY per share. See more details about PORTON PHARMA SOLU earnings.
PORTON PHARMA SOLU revenue for the last quarter amounts to 1.08 B CNY despite the estimated figure of 1.08 B CNY. In the next quarter revenue is expected to reach 1.73 B CNY.
Yes, you can track PORTON PHARMA SOLU financials in yearly and quarterly reports right on TradingView.
300363 stock has risen by 4.17% compared to the previous week, the month change is a 9.49% fall, over the last year PORTON PHARMA SOLU has showed a 50.63% decrease.
300363 net income for the last quarter is 41.49 M CNY, while the quarter before that showed 106.28 M CNY of net income which accounts for −60.97% change. Track more PORTON PHARMA SOLU financial stats to get the full picture.
Today PORTON PHARMA SOLU has the market capitalization of 9.27 B, it has increased by 0.74% over the last week.
Yes, 300363 dividends are paid annually. The last dividend per share was 1.11 CNY. As of today, Dividend Yield (TTM)% is 6.51%. Tracking PORTON PHARMA SOLU dividends might help you take more informed decisions.
PORTON PHARMA SOLU dividend yield was 2.71% in 2022, and payout ratio reached 29.90%. The year before the numbers were 0.22% and 19.74% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 300363 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PORTON PHARMA SOLU stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 5.33 K employees. See our rating of the largest employees — is PORTON PHARMA SOLU on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PORTON PHARMA SOLU technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PORTON PHARMA SOLU stock shows the sell signal. See more of PORTON PHARMA SOLU technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PORTON PHARMA SOLU future price: according to them, 300363 price has a max estimate of 24.00 CNY and a min estimate of 24.00 CNY. Read a more detailed PORTON PHARMA SOLU forecast: see what analysts think of PORTON PHARMA SOLU and suggest that you do with its stocks.